IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION

Active, not recruitingOBSERVATIONAL
Enrollment

6,000

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

June 30, 2030

Study Completion Date

June 30, 2030

Conditions
MyocarditisHeart FailureMyocardial FibrosisVascular Inflammation
Interventions
DIAGNOSTIC_TEST

Cardiac Imaging

Subjects undergo CMR study with contrast agent (gadobutrol 0.1 mmol/kg; mapping, volumes, function, strain and LGE); transthoracic echocardiography and blood testing.

Trial Locations (3)

55131

University Hospital Mainz, Mainz

61231

Kerckhoff Hospital, Bad Nauheim

Frankfurt am Main

University Hospital Frankfurt, Frankfurt am Main

All Listed Sponsors
collaborator

Kerckhoff Klinik

OTHER

collaborator

Johannes Gutenberg University Mainz

OTHER

collaborator

University Hospital Ulm

OTHER

lead

Johann Wolfgang Goethe University Hospital

OTHER

NCT04444128 - IMPRoving Cardiovascular RiSk Stratification Using T1 Mapping in General populatION | Biotech Hunter | Biotech Hunter